#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Encephalopathy neonatal Follicular lymphoma Head and neck cancer Type IIa hyperlipidaemia Vaginal cancer Burkitt's lymphoma Chronic myelomonocytic leukaemia Human papilloma virus immunisation Immunodeficiency common variable Pulmonary hypertension Bronchiectasis Malignant glioma Pancreatic neuroendocrine tumour Pulmonary tuberculosis Marginal zone lymphoma recurrent More trials…

    Learn about Rare Diseases

    Alagille syndrome – Diagnostics Glomerulonephritis membranoproliferative – Trials in Disease Soft tissue sarcoma – Diagnostics Small intestine leiomyosarcoma – Diagnostics Waldenstrom’s macroglobulinaemia refractory – Basic Information Turner’s syndrome – Trials in Disease Loeys-Dietz syndrome – Life with Disease Congenital nephrogenic diabetes insipidus – Life with Disease Breast angiosarcoma – Basic Information Optic glioma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dopamine Hydrochloride Cdr132L Sodium Poloxamer 407 ETX-19477 Gadoteridol Metformin Hydrochloride INCB123667 Ltx-315 RP2 Minocycline Vamorolone GSK5733584 Fentanyl Tafamidis Thiamine Hydrochloride Ribonucleic Acid K30 Ataluren GOCATAMIG Clazakizumab Ambrosia Artemisiifolia (302) More therapies…

    Learn about Your Condition

    Growth hormone deficiency Malignant neoplasm of choroid Primary hypercholesterolaemia Bacterial infection Fibrous dysplasia of bone Pulmonary hypertension Peritoneal abscess Liposarcoma metastatic Thalassaemia beta Hysterectomy Pelvic venous thrombosis Vaginal infection Pruritus Delirium Systemic lupus erythematosus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Acromegaly

  • Study of Debio 4126, a new octreotide formulation, compared to placebo in patients with acromegaly who were previously treated with somatostatin analogs

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acromegaly
    Investigated Drugs:
    • Lanreotide
    • Octreotide
    Austria Belgium Bulgaria Denmark Estonia France +10

  • Study on the Effects of Pegvisomant and Somatropin on Liver Fat Metabolism in Patients with Acromegaly and Healthy Individuals

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acromegaly
    Investigated Drugs:
    • PEGVISOMANT
    • Somatropin
    Austria

  • Study of ALXN2420 with somatostatin analogs for adults with acromegaly to evaluate effectiveness in lowering IGF-1 levels

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Acromegaly
    Investigated Drugs:
    • ALXN2420
    • Octreotide Acetate
    Denmark Hungary Italy Lithuania The Netherlands Poland +1

  • Study on the Long-Term Safety and Efficacy of Paltusotine for Patients with Acromegaly

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Acromegaly
    Investigated Drugs:
    • Paltusotine
    Germany Greece Hungary

  • Study on the Safety and Effectiveness of Paltusotine for Patients with Acromegaly

    Not recruiting

    3 1
    Investigated Drugs:
    • Paltusotine
    Belgium Bulgaria France Hungary Italy Poland

  • Study on the Effects of Paltusotine for Patients with Untreated Acromegaly

    Not recruiting

    3 1
    Investigated Drugs:
    • Paltusotine
    Bulgaria France Germany Greece Hungary Italy +1
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!